Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Renal Cell Cancer AJCC V7”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04071223
What this trial is testing

Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study

Who this might be right for
Advanced Renal Cell CarcinomaChromophobe Renal Cell CarcinomaClear Cell Renal Cell Carcinoma+6 more
National Cancer Institute (NCI) 134
Testing effectiveness (Phase 2)Study completedNCT03587662
What this trial is testing

Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Medullary CarcinomaMetastatic Renal Cell CarcinomaSMARCB1 Negative+2 more
M.D. Anderson Cancer Center 30
Not applicableStudy completedNCT05112627
What this trial is testing

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

Who this might be right for
Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
Mayo Clinic 15
Testing effectiveness (Phase 2)Study completedNCT00042965
What this trial is testing

Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Alliance for Clinical Trials in Oncology 60
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)UnknownNCT00873236
What this trial is testing

MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
Mount Vernon Cancer Centre at Mount Vernon Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT02273752
What this trial is testing

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more
Emory University 2
Testing effectiveness (Phase 2)Study completedNCT00017329
What this trial is testing

PS-341 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00032188
What this trial is testing

Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 65
Not applicableStudy completedNCT00073879
What this trial is testing

Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Kidney Cancer
Baylor College of Medicine
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Testing effectiveness (Phase 2)Study completedNCT00003551
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Emory University
Early research (Phase 1)Study completedNCT00098943
What this trial is testing

NGR-TNF in Treating Patients With Advanced Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck CancerKidney Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)Study completedNCT00378703
What this trial is testing

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 361
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Large-scale testing (Phase 3)Study completedNCT00018941
What this trial is testing

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Very early researchStudy completedNCT00276835
What this trial is testing

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Northwestern University 15
Testing effectiveness (Phase 2)Study completedNCT00045487
What this trial is testing

Erlotinib in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
The University of Texas Health Science Center at San Antonio 41
Next Page